Curaleaf Holdings, Inc.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.

Curaleaf Holdings, Inc. (OTCPK:CURLF) Q1 2023 Earnings Conference Call May 17, 2023 5:00 PM ET Company Participants Camilo Lyon - Chief Investment Officer Boris Jordan - Executive Chairman Matt Darin - Chief Executive Officer Ed Kremer - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Matt McGinley - Needham Scott Fortune - ROTH MKM Andrew Partheniou - Stifel JMP Eric Des Lauriers - Craig-Hallum Capital Group Operator Good afternoon everyone, and welcome to the Curaleaf Holdings Inc. First Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode.

Curaleaf Holdings, Inc. (CURLF) Q1 2023 Earnings Call Transcript

First  quarter 2023 revenue of $336.5 million, representing an increase of 14% year-over-year, and adjusted EBITDA(1) of $73.2 million Operating cash flow from continuing operations of $30.6 million and cash on balance sheet of $115.8 million NEW YORK , May 17, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today reported its financial and operating results for the first quarter ended March 31, 2023. All financial information is reported in accordance with U.S. generally accepted accounting principles (GAAP) and is provided in U.S. dollars unless otherwise indicated.

Curaleaf Reports First Quarter 2023 Results

Top Marijuana Stocks To Watch Half Way Through May The post 2 Marijuana Stocks To Buy Right Now In May? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Marijuana Stocks To Buy Right Now In May?

Curaleaf (CURA) stock price has been in a strong bearish trend in the past few months as the cannabis sector's hype evaporates. The shares plunged to a low of $3.30 on Thursday, meaning that they have fallen by over 85% from the all-time high in 2020.

Curaleaf stock price analysis: sell in May and go away

Bitfarms Ltd

Taboola

Valens Semiconductor Ltd

AppHarvest

Polestar Automotive Holding UK PLC

Waterdrop

Last year was the worst year for the markets since the financial crisis of 2008. While the index slipped, the correction was felt most in growth and penny stocks.

7 Penny Stocks That Are Flying Under the Radar (But Not For Long)

Curaleaf, like its peers in cannabis, is being battered by a bunch of headwinds. It's also shifting out of several regional markets to consolidate in several others.

Is Curaleaf Stock a Buy Now?

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

3 Marijuana Stocks To Research Over The Weekend The post 3 Marijuana Stocks To Watch Before Next Week Trading Begins appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Marijuana Stocks To Watch Before Next Week Trading Begins

Canopy Growth

Cronos Group

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Tilray Brands

Cannabis stocks rose Friday in their second day of big gains. The U.S. Senate committee on banking, housing and urban affairs has scheduled a hearing entitled, “Examining Cannabis Banking Challenges of Small Businesses and Workers” on Thursday at 9:45 a.m.

Cannabis stocks stay hot as Senate banking committee schedules hearing

Trulieve Cannabis has the most retail locations of any MSO. Curaleaf is the largest MSO in terms of revenue.

2 Cannabis Stocks to Consider If the SAFE Banking Act Passes

NEW YORK , May 5, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the first quarter ended March 31, 2023 after market close on May 17, 2023. Management will host a conference call and audio webcast that afternoon at 5:00 p.m.

Curaleaf to Report First Quarter 2023 Financial and Operational Results

NEW YORK , May 5, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc.  (CSE: CURA /OTCQX:  CURLF ) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that members of Curaleaf's executive management team will be participating in the following investor community conferences and events during May 2023. Wolfe Conference 2023 May 11, 2023   Matt Darin, Chief Executive Officer of Curaleaf, will be participating in the Cannabis Roundtable panel discussion from 2:35 – 3:00 PM EST.Curaleaf management will also be hosting investor meetings.

Curaleaf Announces May Conference Participation

Cannabis stocks moved up sharply on Thursday on remarks by a U.S. senator about a potential committee hearing on the Secure and Fair Enforcement (SAFE) Banking Act.

Cannabis stocks rise as SAFE Banking measure gets potential hearing with Senate committee

US multistate cannabis operator Curaleaf Hldgs Inc. (CSE:CURA, OTCQX:CURLF) saw its fourth quarter revenue miss estimates after a “messy” quarter marred by retail closures and headcount reductions. For the three-month period to end December 31, 2022, Curaleaf generated $352.5 million in revenue, a 14% increase year-over-year, but below consensus estimates of $482 million.

Curaleaf misses estimates after "messy" 1Q for US multistate operator

Curaleaf Holdings, Inc. (OTCPK:CURLF) Q4 2022 Earnings Conference Call May 1, 2023 5:00 PM ET Company Participants Camilo Lyon - Chief Investment Officer Boris Jordan - Executive Chairman Matt Darin - Chief Executive Officer Ed Kremer - Chief Financial Officer Conference Call Participants Matt McGinley - Needham Aaron Grey - Alliance Global Partners Matt Bottomley - Canaccord Andrew Partheniou - Stifel JMP Scott Fortune - ROTH MKM Ty Collin - Eight Capital Eric Des Lauriers - Craig-Hallum Operator Good day, and welcome to the Curaleaf Holdings Fourth Quarter 2022 Conference Call. All participants will be in a listen-only mode.

Curaleaf Holdings, Inc. (CURLF) Q4 2022 Earnings Call Transcript

Record fiscal year 2022 revenue of $1.34 billion and Adjusted EBITDA(1) of $305 million, representing an increase of 12% and 17% from fiscal 2021, respectively Fourth quarter 2022 Revenue of $352.5 million, representing an increase of 14% year-over-year, and Adjusted EBITDA(1) of $73 million Operating cash flow of $46 million and cash on balance sheet of $163 million NEW YORK , May 1, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today reported its financial and operating results for the fourth quarter and year ended December 31, 2022. All financial information is reported in accordance with U.S. generally accepted accounting principles (GAAP) and is provided in U.S. dollars unless otherwise indicated.

Curaleaf Reports Fourth Quarter and Fiscal Year End 2022 Results

Compass

WM Technology

Cantor Fitzgerald said Friday it will no longer provide research coverage of 23 cannabis stocks because analyst Pablo Zuanic has departed the firm. Zuanic is now head of Zuanic & Associates, a consulting and research firm aimed at the cannabis sector, according to his LinkedIn profile and a website for the firm.

Cantor Fitzgerald discontinues cannabis stock coverage with analyst departure

Are US Pot Stocks A Buy In May? The post 3 Top Marijuana Stocks For May 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Top Marijuana Stocks For May 2023

Tilray Brands and Curaleaf Holdings shares both climbed nearly 10% on Thursday after a group of bipartisan US Congress members reintroduced the Secure and Fair Enforcement (SAFE) Banking Act in the House and Senate. The proposal would ensure that legal cannabis businesses have access to critical banking and financial services.

Tilray Brands, Curaleaf shares lead cannabis stocks higher as SAFE Banking Act reintroduced

NEW YORK , April 26, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the fourth quarter and fiscal year ended December 31, 2022 after market close on May 1, 2023. Management will host a conference call and audio webcast that afternoon at 5:00 p.m.

Curaleaf to Report Fourth Quarter and Fiscal Year End 2022 Financial and Operational Results

Top Marijuana Stocks To Know About Right Now The post 2 Marijuana Stocks For Your Cannabis Investing 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Marijuana Stocks For Your Cannabis Investing 2023

2 Marijuana Stocks For This Weeks Watchlist The post Investing In Marijuana Stocks 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Investing In Marijuana Stocks 2023

IBM's first-quarter results were “better than feared” after higher margins counteracted the computing firm's revenue miss, said Wedbush.

IBM impresses, good news for Curaleaf, and junior resource companies shine in the analyst calls of the week

In the most recent available quarterly results, revenues rose 7% year-over-year, but losses continued. In January, the company laid off 10% of its workforce and reduced operations in several states.

Curaleaf Faces a Potentially Decisive Year. Will Big States Make a Difference?

It continues to be a long wait for the cannabis industry towards federal level legalization. It was recently reported that Democrat and Republican congressional representatives will file a bill to prepare for legalization.

3 Cannabis Stocks That Could 10X in a Legalization Scenario

Aurora Cannabis

SNDL Inc.

All three of these marijuana stocks have plunged; Aurora has been hit the hardest. Curaleaf is generating the highest operating cash flow of the group, but all remain unprofitable.

How Aurora Cannabis, Curaleaf, and SNDL Stack Up on 420 Day 2023

News for Curaleaf Holdings, Inc. Stock (CURLF)